文献速递临床试验与 GCP流行病学与生物统计

DIADEM-I 试验:低能量饮食联合体力活动的强化生活方式干预对早期2型糖尿病体重与代谢的影响——随机对照试验研究方案

Diabetes Intervention Accentuating Diet and Enhancing Metabolism (DIADEM-I): a randomised controlled trial to examine the impact of an intensive lifestyle intervention consisting of a low-energy diet and physical activity on body weight and metabolism in early type 2 diabetes mellitus: study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2018-05-21

DIADEM-I 是一项正在进行的非盲、实用性、随机对照平行组试验,受试者为18-50岁、病程≤3年的早期2型糖尿病患者,比较低能量饮食代餐联合体力活动的强化生活方式干预与常规医疗照护。主要结局为12个月体重下降,计划纳入138名受试者评估主要结局,同时观察糖尿病缓解、血糖控制、并发症、心血管健康、体力活动、心理健康与生活质量,全程评估安全性。

要点

  • 针对18-50岁、病程≤3年的早期2型糖尿病年轻患者开展强化生活方式干预。
  • 干预为低能量饮食代餐联合体力活动,对照为常规医疗照护,主要结局为12个月体重下降。
  • 计划纳入138名受试者,同时评估糖尿病缓解、血糖控制及心血管健康等结局。

核心结论

  • 若DIADEM-I显示强化生活方式干预对年轻早期2型糖尿病患者有临床显著效果,将为未来2型糖尿病管理指南与服务提供依据。

研究设计与样本

  • 正在进行的非盲、实用性、随机对照、平行组试验,比较低能量饮食代餐联合体力活动的强化生活方式干预与常规医疗照护。
  • 受试者为18-50岁、病程≤3年的早期2型糖尿病患者,计划纳入138名受试者评估主要结局。
  • 主要结局为12个月体重下降,全程评估安全性。

关键数值与推荐

  • 主要结局为12个月体重下降。
  • 其他关键结局包括糖尿病缓解、血糖控制、糖尿病并发症、心血管健康、体力活动、心理健康与生活质量。
  • 受试者年龄18-50岁,糖尿病病程≤3年。
  • 计划纳入138名受试者评估主要结局。

临床怎么用

  • 为年轻早期2型糖尿病患者采用低能量饮食代餐联合体力活动的强化生活方式干预提供随机对照证据。
  • 若干预显示临床显著效果,可支持将强化生活方式干预纳入未来2型糖尿病管理指南与服务。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Type 2 diabetes mellitus (T2DM) and obesity are syndemic and will have a significant impact on affected individuals and healthcare services worldwide. Evidence shows that T2DM remission can be achieved with significant weight loss in those who are younger with early diabetes and requiring fewer medications for glycaemic control. DIADEM-I aims to examine the impact of an intensive lifestyle intervention (ILI) using a low-energy diet (LED) meal replacement approach combined with physical activity in younger individuals with early T2DM. METHODS: The planned study is an ongoing, non-blinded, pragmatic, randomised controlled, parallel-group trial examining the impact of an LED-based ILI on body weight and diabetes remission in younger (18-50 years) T2DM individuals with early diabetes (≤ 3-year duration). The ILI will be compared to usual medical care (UMC). The primary outcome will be weight loss at 12 months. Other key outcomes of interest include diabetes remission, glycaemic control, diabetes complications, cardiovascular health, physical activity, mental health, and quality of life. It is planned for the study to include 138 subjects for assessment of the primary outcome. Safety will be assessed throughout. DISCUSSION: If DIADEM-I demonstrates a clinically significant effect for younger individuals with early T2DM, it will inform clinical guidelines and services of the future for management of T2DM. TRIAL REGISTRATION: ISRCTN: ISRCTN20754766 (date assigned: 7 June 2017); ClinicalTrials.gov, ID: NCT03225339 Registered on 26 June 2017.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Taheri S, Chagoury O, Zaghloul H, et al. Diabetes Intervention Accentuating Diet and Enhancing Metabolism (DIADEM-I): a randomised controlled trial to examine the impact of an intensive lifestyle intervention consisting of a low-energy diet and physical activity on body weight and metabolism in early type 2 diabetes mellitus: study protocol for a randomized controlled trial. Trials. 2018. PMID: 29784059. doi:10.1186/s13063-018-2660-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。